Literature DB >> 7738715

Loss of heterozygosity in ductal carcinoma in situ of the breast.

M R Stratton1, N Collins, S R Lakhani, J P Sloane.   

Abstract

Loss of heterozygosity (LOH) at loci reported to show allele loss in invasive breast cancers was examined in ductal in situ carcinomas of the breast using polymorphic short tandem repeats and the polymerase chain reaction (PCR). LOH was detected at all loci examined in at least 11 per cent of the samples examined. The proportion of cases of in situ carcinoma showing LOH at these loci was similar to that previously reported in invasive cancers. Cases of pure in situ cancer without an invasive component exhibited an overall lower frequency of allele loss. LOH at more than one locus was observed in some intraductal cancers. In a small number of cases, LOH was present in the invasive but not in the intraductal component of the tumour, suggesting that mutation at the locus concerned was associated with development of invasive behaviour.

Entities:  

Mesh:

Year:  1995        PMID: 7738715     DOI: 10.1002/path.1711750207

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

1.  Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; J Hewlett; M P Davies; D R Sibson; J P Sloane
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Precancerous Lesions of the Breast.

Authors:  Annette Lebeau
Journal:  Breast Care (Basel)       Date:  2010-08-03       Impact factor: 2.860

Review 3.  Ductal carcinoma in situ of the breast.

Authors:  M J Silverstein
Journal:  BMJ       Date:  1998-09-12

4.  Microdissection of stained archival tissue.

Authors:  S K Gupta; A G Douglas-Jones; J M Morgan
Journal:  Mol Pathol       Date:  1997-08

Review 5.  Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Authors:  P S Steeg; S E Clare; J A Lawrence; Q Zhou
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 7.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

8.  Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

Authors:  M Kasami; C L Vnencak-Jones; S Manning; W D Dupont; D L Page
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

9.  Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.

Authors:  Lynn C Hartmann; Derek C Radisky; Marlene H Frost; Richard J Santen; Robert A Vierkant; Lorelle L Benetti; Yaman Tarabishy; Karthik Ghosh; Daniel W Visscher; Amy C Degnim
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-30

Review 10.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.